NASDAQ

Updated Nov 3, 7:59 PM ET

AQST

Aquestive Therapeutics, Inc.
$3.77CS band Caution

+$0.11 (2.92%) At close $3.88 · Today

☾After Hours −$0.11 (2.81%) Nov 3, 7:59 PM ET

Mkt Cap
$487M
Volume
2.1M
52W High
$6.85
52W Low
$2.93
PE Ratio
—
Avg Vol
2.1M
As of 11/2/26
Div Yield
—
Beta
0.84
As of 11/2/26

Company

Headquarters
Warren, NJ
Employees
147 (2026)
Listed
Jul 25, 2018
Exchange
Nasdaq
Website
aquestive.com
SEC industry
Pharmaceutical Preparations
Cylvex sector
Health Care · Pharmaceuticals

Pharmaceuticals

  • Market cap #172 of 430
  • P/B #376 of 396

Ranked highest first among stocks Cylvex covers.

  1. LLYEli Lilly and Company$1.26T-0.11%
  2. JNJJohnson & Johnson$640.8B-1.62%
  3. ABBVAbbVie Inc$505.4B-0.98%
  4. MRKMerck & Co Inc$356.9B-2.49%
  5. NVSNovartis AG$300.8B-1.40%
All Pharmaceuticals ›

Financial summary

Related companies

About

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

From company filings and market data · Not investment advice

Price data

Day Low $3.76Day High $3.93
52W Low $2.9352W High $6.85
Open
$3.78
Prev Close
$3.77
Volume
2.1M
Avg Vol (30D)
2.1M

52W range and average volume from daily bars (unadjusted, last 252 sessions).

Financials

Consensus estimates

The information provided is for educational purposes only and does not constitute investment advice. Past performance does not guarantee future results.